HealthcareServices

Biopharmaceutical CMO Industry Insights: Market Forecast to 2029

November 24, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Biopharmaceutical CMO Market Size Likely To Evolve From 2025 Through 2034?

The biopharmaceutical cmo market size has seen rapid expansion in recent years. It is forecast to grow from $24.81 billion in 2024 to $28.02 billion in 2025, at a compound annual growth rate (CAGR) of 12.9%. This historical growth can be attributed to factors including increasing demand for biopharmaceuticals, globalization, a rise in healthcare expenditure, regulatory support, and increased research funding.

The biopharmaceutical cmo market size is projected to experience rapid growth in the coming years, with an expected increase to $47.79 billion by 2029, achieving a compound annual growth rate (CAGR) of 14.3%. The expansion anticipated during this forecast period can be attributed to various factors including the rise in telehealth and remote trials, global health initiatives, an increase in disposable income, and further global health initiatives. Prominent trends throughout this period are expected to include the dominance of advanced therapies, the integration of digitalization and Industry 4.0, the adoption of continuous manufacturing, and a focus on sustainability and green practices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp

Which Industry Drivers Are Expected To Accelerate The Biopharmaceutical CMO Market From 2025 To 2029?

The rising elderly population is projected to boost the biopharmaceutical CMO market’s expansion. Individuals over 60 years old face a higher risk of experiencing cardiovascular events like heart attacks, strokes, and the development of coronary heart disease and heart failure compared to younger demographics. This growth in the older demographic is a result of improved healthcare, decreasing birth rates, and the aging process of the baby boomer generation. The expanding geriatric population is fueling the need for biopharmaceutical treatments designed for age-associated conditions, including cardiovascular disorders. In this context, biopharmaceutical CMOs are crucial, offering specialized production capacities for intricate biologics and customized medications to meet these requirements. For example, data from January 2024, reported by the US-based non-profit organization, Population Reference Bureau, indicates that the population of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Consequently, the growing geriatric population is a key driver for the biopharmaceutical CMO market’s expansion.

What Are The Major Segments Identified In The Biopharmaceutical CMO Market?

The biopharmaceutical cmomarket covered in this report is segmented –

1) By Product: Biologics; Biosimilars

2) By Source: Mammalian; Non-Mammalian

3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Cell and Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies; Biosimilar Recombinant Proteins; Biosimilar Insulins; Biosimilar Growth Hormones

Which Competitive Trends Are Defining The Biopharmaceutical CMO Market Structure?

Technological advancement represents a significant trend gaining traction within the biopharmaceutical CMO market. Major companies in this market are making progress in their new technologies and research and development efforts utilizing IoT. The Internet of Things (IoT) involves the application of networked sensors and actuators to regulate and observe the environment, the objects moving within it, and the individuals operating within it. A considerable amount of data can be generated by sensors, actuators, and other components integrated into manufacturing machinery and networked computer systems. This data can be analyzed to gain insights and identify opportunities to improve production efficiency, automate monitoring and control functions, and enable adaptable manufacturing systems. For instance, in February 2022, M2Cloud, a Korea-based bio-cold chain technology company, collaborated with Thales, a France-based firm specializing in IoT communication modules, to develop an IoT-based LTE monitoring system for biopharmaceutical monitoring. This system is valuable for real-time surveillance of freezers, refrigerated warehouses, and similar facilities, alongside tracking delivery boxes in real-time. It enables remote verification of temperature and position information instantly by simply powering it on. With technologies specifically designed for biopharmaceutical management, it enhances the safety of pharmaceutical products.

Which Major Industry Participants Are Leading The Biopharmaceutical CMO Market Growth?

Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

How Do Regional Market Performances Compare Within The Biopharmaceutical CMO Industry?

North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Biopharmaceutical CMO Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical CMO Market 2025, By The Business Research Company

Animal And Pet Food Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-and-pet-food-global-market-report

Greenhouse Nursery And Flowers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/greenhouse-nursery-and-flowers-global-market-report

Crop Production Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crop-production-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795